Literature DB >> 19020513

Beyond polemics: science and ethics of ADHD.

Ilina Singh1.   

Abstract

What is attention-deficit hyperactivity disorder (ADHD)? Why are so many children being diagnosed with ADHD and prescribed medication? Are stimulant drugs an effective and safe treatment strategy? This article explores the current state of scientific research into ADHD and the key social and ethical concerns that are emerging from the sharp rise in the number of diagnoses and the use of stimulant drug treatments in children. Collaborations among scientists, social scientists and ethicists are likely to be the most promising route to understanding what ADHD is and what stimulant drugs do.

Entities:  

Mesh:

Year:  2008        PMID: 19020513     DOI: 10.1038/nrn2514

Source DB:  PubMed          Journal:  Nat Rev Neurosci        ISSN: 1471-003X            Impact factor:   34.870


  39 in total

1.  Stimulant ADHD medication and risk for substance abuse.

Authors:  Zheng Chang; Paul Lichtenstein; Linda Halldner; Brian D'Onofrio; Eva Serlachius; Seena Fazel; Niklas Långström; Henrik Larsson
Journal:  J Child Psychol Psychiatry       Date:  2013-10-25       Impact factor: 8.982

Review 2.  Globalization and cognitive enhancement: emerging social and ethical challenges for ADHD clinicians.

Authors:  Ilina Singh; Angela M Filipe; Imre Bard; Meredith Bergey; Lauren Baker
Journal:  Curr Psychiatry Rep       Date:  2013-09       Impact factor: 5.285

Review 3.  Is Adult Attention-Deficit Hyperactivity Disorder Being Overdiagnosed?

Authors:  Joel Paris; Venkat Bhat; Brett Thombs
Journal:  Can J Psychiatry       Date:  2015-07       Impact factor: 4.356

4.  ADHD Medication and Substance-Related Problems.

Authors:  Patrick D Quinn; Zheng Chang; Kwan Hur; Robert D Gibbons; Benjamin B Lahey; Martin E Rickert; Arvid Sjölander; Paul Lichtenstein; Henrik Larsson; Brian M D'Onofrio
Journal:  Am J Psychiatry       Date:  2017-06-29       Impact factor: 18.112

Review 5.  ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis.

Authors:  Guilherme V Polanczyk; Erik G Willcutt; Giovanni A Salum; Christian Kieling; Luis A Rohde
Journal:  Int J Epidemiol       Date:  2014-01-24       Impact factor: 7.196

6.  Independent review of social and population variation in mental health could improve diagnosis in DSM revisions.

Authors:  Helena B Hansen; Zoe Donaldson; Bruce G Link; Peter S Bearman; Kim Hopper; Lisa M Bates; Keely Cheslack-Postava; Kristin Harper; Seth M Holmes; Gina Lovasi; Kristen W Springer; Julien O Teitler
Journal:  Health Aff (Millwood)       Date:  2013-04-24       Impact factor: 6.301

Review 7.  Disagreements with implications: diverging discourses on the ethics of non-medical use of methylphenidate for performance enhancement.

Authors:  Cynthia Forlini; Eric Racine
Journal:  BMC Med Ethics       Date:  2009-07-06       Impact factor: 2.652

8.  Changes in the diagnosis of autism: how parents and professionals act and react in France.

Authors:  B Chamak; B Bonniau
Journal:  Cult Med Psychiatry       Date:  2013-09

Review 9.  Context-dependent dynamic processes in attention deficit/hyperactivity disorder: differentiating common and unique effects of state regulation deficits and delay aversion.

Authors:  Edmund J S Sonuga-Barke; Jan R Wiersema; Jacob J van der Meere; Herbert Roeyers
Journal:  Neuropsychol Rev       Date:  2009-09-15       Impact factor: 7.444

10.  Focusing on Cause or Cure?: Priorities and Stakeholder Presence in Childhood Psychiatry Research.

Authors:  Lauren C Milner; Mildred K Cho
Journal:  AJOB Prim Res       Date:  2014-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.